2024 Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working party Group Acute Leukemia Working Party (ALWP) 1st listed author Jean El Cheikh Journal Bone Marrow Transplant.
2024 Management of complications of chimeric antigen receptor T-cell therapy: a report by the European Society of Blood and Marrow Transplantation Group Transplant Complications Working Party (TCWP) 1st listed author Olaf Penack Journal Haematologica.
2024 Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patient Group Acute Leukemia Working Party (ALWP) 1st listed author Ann-Kristin Schmälter Journal Blood Cancer J.
2024 Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) Global Committee 1st listed author Yishan Ye Journal Blood Cancer J.
2024 Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee Group Chronic Malignancies Working Party (CMWP) Practice Harmonisation and Guidelines Committee 1st listed author Donal P McLornan Journal Leukemia.
2024 Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) Practice Harmonisation and Guidelines Committee 1st listed author Simona Pagliuca Journal Lancet Haematol.
2024 Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Raynier Devillier Journal Am J Hematol.
2024 Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Group Acute Leukemia Working Party (ALWP) 1st listed author Abdul-Hamid Bazarbachi Journal Cancer.
2024 ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation? Group Transplant Complications Working Party (TCWP) 1st listed author Olaf Penack Journal Leukemia.
2024 Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight Johannes Schetelig Group Cellular Therapy & Immunobiology Working Party (CTIWP) Other society 1st listed author Johannes Schetelig Journal Front Immunol.
2024 Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC) Group Chronic Malignancies Working Party (CMWP) 1st listed author Christian Niederwieser Journal Bone Marrow Transplant.
2024 Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WP Group Paediatric Diseases Working Party (PDWP) 1st listed author Jacek Wachowiak Journal Bone Marrow Transplant.